ACM
NLSPW

AIGH Capital Management’s NLS Pharmaceutics Warrant NLSPW Stock Holding History

AIGH Capital Management’s Portfolio NLSPW Stock Details NLSPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-633,361
Closed -$112K – 55
2022
Q3 		$158K Buy
+633,361
New +$130K 0.05% 46

Other funds holding NLSPW

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
AC
Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

AIGH Capital Management's NLSPW Position: Q4 2022 in Review

AIGH Capital Management sold out of NLS Pharmaceutics Warrant (NLSPW) in Q4 2022, closing a stake of 633,361 shares — an estimated $112K sold.

AIGH Capital Management first reported a position in NLSPW in Q3 2022 and held it in 1 quarter. The position peaked at $158K in Q3 2022. 5 funds tracked by Wall St. Rank hold NLSPW as of Q4 2022.

  • AIGH Capital Management reported no remaining NLS Pharmaceutics Warrant position as of Q4 2022 after selling out during the quarter.
  • AIGH Capital Management sold 633,361 NLS Pharmaceutics Warrant shares in Q4 2022, an estimated $112K.
  • AIGH Capital Management first reported a position in NLS Pharmaceutics Warrant in Q3 2022 and held it in 1 quarter.
  • AIGH Capital Management's NLS Pharmaceutics Warrant position peaked at $158K in Q3 2022.
  • 5 funds tracked by Wall St. Rank held NLS Pharmaceutics Warrant as of Q4 2022.

Based on AIGH Capital Management's 13F filing for Q4 2022, filed 15 Feb 2023.